Hostname: page-component-848d4c4894-r5zm4 Total loading time: 0 Render date: 2024-06-29T16:36:15.204Z Has data issue: false hasContentIssue false
  • English
  • Français

The usage of clozapine in a patient with schizophrenia and epilepsy: A case report

Published online by Cambridge University Press:  13 August 2021

M. Karnickas ,
G. Bulotaite  and
V. Rutkauskas
M. Karnickas
Affiliation:
Institute Of Clinical Medicine, Clinic Of Psychiatry, Vilnius University Faculty of Medicine, Vilnius, Lithuania
G. Bulotaite
Affiliation:
Faculty Of Medicine, Vilnius University, Vilnius, Lithuania
V. Rutkauskas*
Affiliation:
Institute Of Clinical Medicine, Clinic Of Psychiatry, Vilnius University Faculty of Medicine, Vilnius, Lithuania Institute Of Health Sciences, Department Of Public Health, Vilnius University Faculty of Medicine, Vilnius, Lithuania
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The usage of clozapine in patients with schizophrenia and epilepsy raises many challenges due to the epileptogenic effects of the drug. There is little data about using clozapine for treatment of treatment-resistant schizophrenia (TRS) accompanied by epilepsy.

Objectives

To present a case report illustrating a patient diagnosed with epilepsy and TRS, successfully treated with clozapine.

Methods

A literature review on “PubMed” database was conducted, using the keywords: clozapine, antipsychotics, epilepsy, seizures, psychoses. Information regarding the clinical case was obtained by consulting the patient’s file.

Results

We present a woman, 33 years old with mild intellectual disability and a 10-year history of schizophrenia. At the age of 24, the patient lost consciousness and experienced tonic – clonic seizure, but epilepsy was not diagnosed. The patient was hospitalized multiple times due to positive symptoms of schizophrenia and suicidal thoughts. Various combinations of neuroleptics and electroconvulsive therapy were used for treatment without therapeutic effect. At the age of 32, a diagnosis of TRS was established, leading to treatment with a moderate clozapine dose (400mg/day). At the fifth month of treatment with clozapine un episode of generalized seizures occurred, leading to a diagnosis of idiopathic generalized epilepsy. Since then, the patient was treated with levetiracetam and the dosage of clozapine was lowered to 275mg/d. The seizures did not re-occur and clinical response to the psychiatric treatment was positive.

Conclusions

This case report highlights how clozapine can be used safely and effectively for patients with TRS and epilepsy and how the epileptogenic effects can be moderated by using antiepileptics in the overall treatment scheme.

Disclosure

No significant relationships.

Keywords

clozapineEpilepsytreatment resistant schizophreniaseizures
Type
Abstract
Information
European Psychiatry , Volume 64 , Special Issue S1: Abstracts of the 29th European Congress of Psychiatry , April 2021 , pp. S808
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.